Study details
Enrolling now
A Phase 0 Trial of PBA-0111
Pure Biologics S.A.
NCT IDNCT06700070ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
12
Study length
about 9 months
Ages
18+
Locations
1 site in LA
About this study
This trial is testing a new drug called PBA-0111 in people with certain types of cancer. The drug will be given directly into the tumor (intratumorally) at a very small dose using a special device. The goal is to see how the drug affects the area around the tumor.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take PBA-0111
PhaseEARLY_Phase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Number of Patients with Adverse Events
Body systems
Oncology